An Empirical Benchmarking Analysis of Generative AI Models vs. Traditional Heuristics for Codon Optimization, Structural Stability, and Cost Efficiency in mRNA Vaccine Engineering
(1) Background: Messenger RNA (mRNA) vaccine and therapeutic development require navigating an astronomical sequence design space (exceeding 2.4 x 10^632 possible synonymous candidate sequences for a standard viral spike glycoprotein). Conventional codon-optimization algorithms rely on rule-based frequency heuristics that are computationally brittle, expensive to iterate through empirical wet-lab screening cycles, and frequently fail to co-optimize mRNA secondary structure folding stability (Delta G) alongside ribosomal translation efficiency. (2) Methods: We present a rigorous empirical benchmarking evaluation comparing three representative sequence optimization paradigms: traditional frequency-table heuristics (Baseline Heuristic), thermodynamic folding-aware sliding-window optimization (Intermediate Thermodynamic), and deep generative transformer and lattice-based computational linguistics engines (SOTA Generative AI). The pipelines are evaluated across curated viral and therapeutic open reading frames (ORFs)—including SARS-CoV-2 Spike, Influenza A Hemagglutinin, Ebola Glycoprotein, Human Erythropoietin, and EGFP reporter constructs—quantifying design wall-clock time (T_design), Codon Adaptation Index (CAI), GC-content balance, minimum free energy (Delta G), and estimated preclinical research and development cost (Delta USD). (3) Results: Empirical benchmarking reveals that while Baseline Heuristics execute rapidly (0.020 s mean design time), they yield suboptimal codon adaptation (mean CAI = 0.742 +/- 0.026) and high preclinical synthesis iteration costs (125.00 USD/kb). Intermediate Thermodynamic methods improve codon adaptation (mean CAI = 0.820 +/- 0.018) and reduce estimated R&D costs to 75.00 USD/kb at the expense of increased compute overhead (0.090 s). Conversely, SOTA Generative AI models achieve superior translational adaptation (mean CAI = 0.942 +/- 0.008) with high statistical consistency, maintaining balanced GC-content (51.33% +/- 12.83%) and strong structural stability (mean Delta G = -111.72 +/- 8.48 kcal/mol) while reducing estimated preclinical R&D synthesis expenditure by 72.0% (down to 35.00 USD/kb). (4) Conclusions: We formalize these empirical trade-offs into a multi-criteria decision framework to guide computational biologists, bioinformaticians, and pharmaceutical R&D architects in selecting optimal sequence engineering pipelines.
Authors
- Md Zahid Hasan (ORCID: https://orcid.org/0009-0001-2616-5685)
Institutions
- Czech University of Life Sciences Prague (CZ)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.5281/zenodo.24325566
- Primary Topic
- RNA and protein synthesis mechanisms
- Type
- preprint